Meta Biomed Co., Ltd. (KOSDAQ:059210)
6,320.00
+30.00 (0.48%)
At close: Sep 15, 2025
Meta Biomed Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 17,593 | 22,402 | 10,080 | 2,628 | 9,522 | -4,093 | Upgrade |
Depreciation & Amortization | 5,168 | 4,981 | 4,223 | 3,860 | 3,571 | 3,941 | Upgrade |
Loss (Gain) From Sale of Assets | -888.26 | 0.91 | -12.62 | -1,212 | -1,160 | 95.87 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | 1,015 | 487.37 | 541.23 | 4,661 | Upgrade |
Loss (Gain) From Sale of Investments | 99.67 | -349.53 | -90.29 | -53.65 | -51.16 | 260.6 | Upgrade |
Loss (Gain) on Equity Investments | -1,184 | -1,181 | -682.88 | -373.09 | -537.62 | -468.69 | Upgrade |
Provision & Write-off of Bad Debts | 525.47 | 444.66 | -158.44 | -172.39 | -1,376 | 8.39 | Upgrade |
Other Operating Activities | 6,760 | -1,451 | -2,926 | 2,115 | -1,637 | 57.12 | Upgrade |
Change in Accounts Receivable | -3,739 | 593.08 | 186.61 | -1,024 | -171.24 | 2,190 | Upgrade |
Change in Inventory | -6,266 | -2,514 | -470.44 | 926.99 | 2,038 | -1,989 | Upgrade |
Change in Accounts Payable | 3,160 | -807.66 | 304.05 | 93.14 | -1,503 | -513.05 | Upgrade |
Change in Other Net Operating Assets | -807.97 | 513.17 | -1,251 | 1,884 | 1,900 | 712 | Upgrade |
Operating Cash Flow | 20,422 | 22,633 | 10,217 | 9,159 | 11,136 | 4,862 | Upgrade |
Operating Cash Flow Growth | 7.75% | 121.52% | 11.55% | -17.75% | 129.06% | 69.70% | Upgrade |
Capital Expenditures | -10,324 | -10,914 | -11,489 | -15,395 | -2,067 | -2,227 | Upgrade |
Sale of Property, Plant & Equipment | 139.49 | 61.83 | 128.06 | 7.45 | 1,413 | 6.53 | Upgrade |
Cash Acquisitions | - | - | - | -2,295 | -2.45 | - | Upgrade |
Divestitures | 8.32 | - | - | - | 535.01 | - | Upgrade |
Sale (Purchase) of Intangibles | -156.25 | -188.9 | -5.43 | 85.95 | -33.29 | -824.5 | Upgrade |
Investment in Securities | -4,781 | -32,421 | 1,116 | -167.9 | 6,349 | -7,464 | Upgrade |
Other Investing Activities | 564.69 | 98.4 | -1,451 | 3,186 | 130 | 593.94 | Upgrade |
Investing Cash Flow | -14,549 | -43,363 | -11,701 | -14,578 | 6,324 | -9,915 | Upgrade |
Long-Term Debt Issued | - | 60,700 | 11,375 | 37,083 | 1,949 | 16,759 | Upgrade |
Long-Term Debt Repaid | - | -36,544 | -11,940 | -27,828 | -17,827 | -5,123 | Upgrade |
Net Debt Issued (Repaid) | -7,079 | 24,156 | -565.37 | 9,255 | -15,878 | 11,635 | Upgrade |
Repurchase of Common Stock | -140.74 | -140.74 | - | -63.26 | - | - | Upgrade |
Dividends Paid | -684.93 | -457.42 | -457.42 | -458.02 | -229.01 | -232.67 | Upgrade |
Other Financing Activities | -1,610 | -148 | -0 | - | 0 | 0 | Upgrade |
Financing Cash Flow | -9,515 | 23,410 | -1,023 | 8,734 | -16,107 | 11,403 | Upgrade |
Foreign Exchange Rate Adjustments | 230.36 | 1,041 | 77.02 | -201.36 | 121.38 | -60.48 | Upgrade |
Miscellaneous Cash Flow Adjustments | 0 | 0 | - | -0 | 0 | - | Upgrade |
Net Cash Flow | -3,411 | 3,721 | -2,430 | 3,113 | 1,474 | 6,288 | Upgrade |
Free Cash Flow | 10,099 | 11,719 | -1,271 | -6,236 | 9,069 | 2,634 | Upgrade |
Free Cash Flow Growth | 69.01% | - | - | - | 244.28% | - | Upgrade |
Free Cash Flow Margin | 10.16% | 12.46% | -1.53% | -9.04% | 15.43% | 5.85% | Upgrade |
Free Cash Flow Per Share | 368.64 | 432.22 | -55.59 | -272.48 | 396.00 | 114.32 | Upgrade |
Cash Interest Paid | 1,902 | 2,094 | 2,176 | 1,259 | 733.31 | 1,278 | Upgrade |
Cash Income Tax Paid | 677.41 | 163.57 | 80 | 379.03 | 357.43 | 293.62 | Upgrade |
Levered Free Cash Flow | -11,199 | 6,742 | -3,338 | -6,175 | 5,650 | 1,895 | Upgrade |
Unlevered Free Cash Flow | -8,840 | 9,081 | -1,891 | -5,306 | 6,366 | 2,527 | Upgrade |
Change in Working Capital | -7,652 | -2,215 | -1,231 | 1,880 | 2,263 | 399.26 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.